Aster DM expected to contain debt levels despite lower profitability: ICRA
The stable outlook reflects ICRA's expectations that the group's track record besides diversification across segments and geographies will aid in mitigating the impact of external circumstances like Covid-19 to some extent.;
New Delhi: Investment information agency ICRA has reaffirmed Aster DM Healthcare's ratings on various financial instruments worth Rs 266 crore at A-minus and A2-plus, and assigned them for enhanced limits.
The stable outlook reflects ICRA's expectations that the group's track record besides diversification across segments and geographies will aid in mitigating the impact of external circumstances like Covid-19 to some extent.
Moreover, the group is undertaking various cost-containment measures and reducing capital expenditure which is expected to contain debt levels despite the lower profitability anticipated in FY21.
The ratings take into account Aster DM's established market position in the healthcare industry across the Gulf Cooperation Council (GCC) countries and growing presence in India. They are also supported by the group's diversified revenue sources from various healthcare segments like hospitals, clinics, and pharmacies, said ICRA.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.